Stock GENB AS
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar GENB AS Other OTC

Equities

US3723032062

Chart calendar GENB AS

fcb103.5Q0GQDKxq11yI5jrzEADolSRW1s47fUgpMuDCq9GB38.oGhhGEPuwQwiefCurRlVkCDUaCxVwJwN9vzuOpghfjGBblY3auniPjF7qA~428e2b4e4ff275243ed75f5b63ad979c

Upcoming events on GENB AS

02/06/2024 22:30 American Society of Clinical Oncology Meeting - Abstract No:7015
02/06/2024 22:30 American Society of Clinical Oncology Meeting - Abstract No:7014
03/06/2024 14:00 American Society of Clinical Oncology Meeting - Abstract No:6012
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No:TPS7084
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No:7039
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No:7037
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No:7032
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No:7029
03/06/2024 15:00 American Society of Clinical Oncology Meeting - Abstract No:5531
14/06/2024 08:00 European Hematology Association Meeting - Abstract Number :P2059
14/06/2024 08:00 European Hematology Association Meeting - Abstract Number :P2081
14/06/2024 08:00 European Hematology Association Meeting - Abstract Number :PB2955
14/06/2024 08:00 European Hematology Association Meeting - Abstract Number :P2060
14/06/2024 13:45 European Hematology Association Meeting - Abstract Number :S239
14/06/2024 13:45 European Hematology Association Meeting - Abstract Number :S163

Past events on GENB AS

Today 15:00 American Society of Clinical Oncology Meeting - Abstract No:2533
02/05/2024 17:00 Q1 2024 Earnings Call
02/05/2024 16:01 Q1 2024 Earnings Release
03/04/2024 12:00 Acquisition of ProfoundBio by Genmab A/S Call
13/03/2024 13:00 Annual General Meeting
05/03/2024 TD Cowen Health Care Conference
27/02/2024 UBS European Healthcare Conference
14/02/2024 17:00 Q4 2023 Earnings Call
14/02/2024 16:02 Q4 2023 Earnings Release
10/01/2024 19:15 JPMorgan Healthcare Conference
12/12/2023 16:00 R&D Day
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number 5089
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number 4757
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number 5158
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number 4481
12/12/2023 02:00 American Society of Hematology Meeting - Abstract Number 4457
11/12/2023 02:00 American Society of Hematology Meeting - Abstract Number 3135
11/12/2023 02:00 American Society of Hematology Meeting - Abstract Number 3092
11/12/2023 02:00 American Society of Hematology Meeting - Abstract Number 3053
10/12/2023 17:30 American Society of Hematology Meeting - Abstract Number 438

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million DKK		Released
Forecast
Spread 		5 366
5 159
4.02%		10 111
9 843
2.72%		8 482
8 376
1.26%		14 595
14 068
3.75%		16 474
16 380
0.58%
19 799

EBITDA
Million DKK		Released
Forecast
Spread 		2 777
2 460
12.89%		6 572
6 099
7.75%		3 266
3 111
4.98%		6 719
6 371
5.46%		5 616
5 721
-1.83%
6 351

EBIT
Million DKK		Released
Forecast
Spread 		2 638
2 317
13.83%		6 313
5 967
5.79%		3 018
2 960
1.96%		6 357
6 008
5.81%		5 321
5 398
-1.42%
5 363

Earnings before Tax (EBT)
Million DKK		Released
Forecast
Spread 		2 859
2 645
8.11%		5 904
5 723
3.17%		3 983
3 731
6.77%		7 035
8 905
-21%		5 637
6 236
-9.6%
5 861

Net income
Million DKK		Released
Forecast
Spread 		2 166
2 085
3.89%		4 758
4 706
1.1%		3 008
2 847
5.64%		5 522
6 793
-18.71%		4 352
4 989
-12.77%
4 672

EPS
DKK		Released
Forecast
Spread 		34,0
32,8
3.61%		72,2
69,4
4.06%		45,5
43,8
3.94%		83,7
104
-19.22%		66,0
76,2
-13.35%
68,0

Announcement Date19/02/2023/02/2116/02/2222/02/2314/02/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2021 S1 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1
Net sales
Million DKK		Released
Forecast
Spread 		6 343
6 164
2.9%		3 553
3 224
10.2%		2 619
2 538
3.19%		2 119
2 074
2.15%		3 162
2 833
11.6%		5 281
5 136
2.82%		4 087
3 634
12.46%		5 227
4 727
10.57%		2 854
2 809
1.62%		4 198
4 070
3.13%		7 052
6 896
2.26%		4 744
4 474
6.03%		4 678
4 610
1.48%		4 143
3 974
4.25%
4 992


9 039


5 286


5 585


5 224

EBITDA
Million DKK		Released
Forecast
Spread 		4 583
4 480
2.3%		1 345
980
37.24%		1 016
776
30.87%		529
358
47.73%		1 263
1 312
-3.74%		1 792
1 951
-8.15%		1 953
1 583
23.36%		2 974
2 708
9.84%		458
583
-21.48%		1 520
1 670
-8.96%		1 978
2 145
-7.79%		1 739
1 646
5.65%		1 899
1 804
5.28%		823
834
-1.33%
1 512


2 412


1 716


2 085


2 841

EBIT
Million DKK		Released
Forecast
Spread 		4 568
4 389
4.08%		1 319
864
52.66%		809
772
4.76%		514
442
16.3%		1 247
1 156
7.87%		1 761
1 814
-2.92%		1 931
1 541
25.34%		2 665
2 314
15.17%		437
527
-17.08%		1 497
1 573
-4.85%		1 934
1 977
-2.18%		1 717
1 702
0.87%		1 670
1 772
-5.73%		801
765
4.72%
392


2 229


1 633


1 832


1 541

Earnings before Tax (EBT)
Million DKK		Released
Forecast
Spread 		4 682
4 682
0%		1 846
1 759
4.95%		966
772
25.06%		612
499
22.59%		2 489
1 183
110.39%		3 101
1 932
60.51%		3 272
1 584
106.63%		662
2 199
-69.9%		286
402
-28.85%		1 723
1 602
7.57%		2 009
1 927
4.26%		2 702
1 774
52.33%		926
1 888
-50.95%		1 716
744
130.64%
184


3 374


1 693


1 715


1 627

Net income
Million DKK		Released
Forecast
Spread 		3 647
4 573
-20.25%		1 402
1 372
2.19%		716
603
18.69%		465
357
30.19%		1 891
913
107.1%		2 356
1 469
60.38%		2 582
1 187
117.46%		584
1 556
-62.47%		226
397
-43.08%		1 357
1 204
12.72%		1 583
1 503
5.32%		2 129
1 382
54.01%		640
1 439
-55.52%		1 325
736
79.97%
455


2 598


1 360


1 345


1 274

EPS
DKK		Released
Forecast
Spread 		55,5
70,2
-20.91%		21,3
20,9
1.67%		10,8
9,25
16.99%		7,05
5,39
30.88%		28,7
13,8
106.99%		35,7
22,1
61.58%		39,2
18,3
113.88%		8,82
23,2
-61.91%		3,43
5,07
-32.28%		20,6
19,3
7.03%		24,0
22,7
5.86%		32,3
21,2
52.42%		9,67
23,0
-57.93%		20,2
8,93
126.09%
-2,27


39,5


19,3


18,9


14,8

Announcement Date12/08/2011/08/2116/02/2211/05/2210/08/2210/08/2209/11/2222/02/2310/05/2303/08/2303/08/2307/11/2314/02/2402/05/24-----

Upcoming sector events for GENB AS

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for GENB AS

17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 13:00 IMMUNOME, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. GMAB Stock
  4. Stock
  5. Calendar GENB AS